"I feel it is the right time for me to pass the baton and let new leadership take the Company into its next phase with the abuse deterrent technology. I remain very optimistic about Elite's future."

Elite will announce its fiscal year ended March 31, 2013 results on or before July 1, 2013 and will host a conference call shortly after the filing to discuss the results and provide guidance on the developments in the opioid space.

I can't be the only one excited to hear what they have to say, haha.